JW Pharmaceutical Corp - Asset Resilience Ratio

Latest as of September 2025: 8.17%

JW Pharmaceutical Corp (001065) has an Asset Resilience Ratio of 8.17% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore 001065 total assets for the complete picture of this company's asset base.

Liquid Assets

₩49.95 Billion

≈ $33.85 Million USD Cash + Short-term Investments

Total Assets

₩611.56 Billion

≈ $414.44 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how JW Pharmaceutical Corp's Asset Resilience Ratio has changed over time. See net asset quality index of JW Pharmaceutical Corp to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down JW Pharmaceutical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 001065 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩49.95 Billion	8.17%
Total Liquid Assets	₩49.95 Billion	8.17%

Asset Resilience Insights

Limited Liquidity: JW Pharmaceutical Corp maintains only 8.17% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

JW Pharmaceutical Corp Industry Peers by Asset Resilience Ratio

Compare JW Pharmaceutical Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Guizhou Bailing Group Pharmaceutical Co Ltd SHE:002424	Drug Manufacturers - Specialty & Generic	2.09%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.15%

Annual Asset Resilience Ratio for JW Pharmaceutical Corp (2014–2024)

The table below shows the annual Asset Resilience Ratio data for JW Pharmaceutical Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	3.66%	₩22.12 Billion ≈ $14.99 Million	₩604.60 Billion ≈ $409.73 Million	-8.48pp
2023-12-31	12.14%	₩78.29 Billion ≈ $53.05 Million	₩645.04 Billion ≈ $437.13 Million	-6.30pp
2022-12-31	18.44%	₩115.78 Billion ≈ $78.46 Million	₩627.97 Billion ≈ $425.57 Million	+13.34pp
2021-12-31	5.10%	₩32.30 Billion ≈ $21.89 Million	₩633.05 Billion ≈ $429.01 Million	-3.06pp
2020-12-31	8.17%	₩44.84 Billion ≈ $30.39 Million	₩549.09 Billion ≈ $372.11 Million	+8.16pp
2016-12-31	0.00%	₩20.00 Million ≈ $13.55K	₩651.08 Billion ≈ $441.23 Million	0.00pp
2015-12-31	0.00%	₩30.00 Million ≈ $20.33K	₩613.48 Billion ≈ $415.75 Million	0.00pp
2014-12-31	0.01%	₩30.00 Million ≈ $20.33K	₩589.24 Billion ≈ $399.32 Million	--

pp = percentage points

About JW Pharmaceutical Corp

KO:001065 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$335.70 Million

₩495.37 Billion KRW

Market Cap Rank

#14498 Global

#479 in Korea

Share Price

₩24650.00

Change (1 day)

-2.18%

52-Week Range

₩24650.00 - ₩30000.00

All Time High

₩88605.96